These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9019299)

  • 1. On-line high-performance liquid chromatographic-electrospray ionization mass spectrometric method for the study of tamoxifen metabolism.
    Jones RM; Yuan ZX; Lamb JH; Lim CK
    J Chromatogr A; 1996 Jan; 722(1-2):249-55. PubMed ID: 9019299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.
    Lim CK; Yuan ZX; Lamb JH; White IN; De Matteis F; Smith LL
    Carcinogenesis; 1994 Apr; 15(4):589-93. PubMed ID: 8149466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen metabolism in rat liver microsomes: identification of a dimeric metabolite derived from free radical intermediates by liquid chromatography/mass spectrometry.
    Jones RM; Yuan ZX; Lim CK
    Rapid Commun Mass Spectrom; 1999; 13(4):211-5. PubMed ID: 10097399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.
    Jarman M; Poon GK; Rowlands MG; Grimshaw RM; Horton MN; Potter GA; McCague R
    Carcinogenesis; 1995 Apr; 16(4):683-8. PubMed ID: 7728943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.
    Notley LM; Crewe KH; Taylor PJ; Lennard MS; Gillam EM
    Chem Res Toxicol; 2005 Oct; 18(10):1611-8. PubMed ID: 16533026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
    Dehal SS; Kupfer D
    Cancer Res; 1996 Mar; 56(6):1283-90. PubMed ID: 8640815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and mechanism of formation of potentially genotoxic metabolites of tamoxifen: study by LC-MS/MS.
    Lim CK; Yuan ZX; Jones RM; White IN; Smith LL
    J Pharm Biomed Anal; 1997 Jun; 15(9-10):1335-42. PubMed ID: 9226561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of tamoxifen and its metabolites by on-line capillary electrophoresis-electrospray ionization mass spectrometry employing nonaqueous media containing surfactants.
    Lu W; Poon GK; Carmichael PL; Cole RB
    Anal Chem; 1996 Feb; 68(4):668-74. PubMed ID: 8999741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
    Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
    J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen.
    Crewe HK; Notley LM; Wunsch RM; Lennard MS; Gillam EM
    Drug Metab Dispos; 2002 Aug; 30(8):869-74. PubMed ID: 12124303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid drug metabolite profiling using fast liquid chromatography, automated multiple-stage mass spectrometry and receptor-binding.
    Lim HK; Stellingweif S; Sisenwine S; Chan KW
    J Chromatogr A; 1999 Jan; 831(2):227-41. PubMed ID: 10070764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inhibitors on the biotransformation of tamoxifen by female rat and mouse liver slices and homogenates.
    Jordan CG; Brown K; Beedham C; Brown JE
    Drug Metabol Drug Interact; 1999; 15(4):239-58. PubMed ID: 10716039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of metabolism of tamoxifen by rat liver microsomes. Identification of a new metabolite: E-1-[4-(2-dimethylaminoethoxy)-phenyl]-1, 2-diphenyl-1-buten-3-ol N-oxide.
    McCague R; Seago A
    Biochem Pharmacol; 1986 Mar; 35(5):827-34. PubMed ID: 3954788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
    Poon GK; Chui YC; McCague R; Lłnning PE; Feng R; Rowlands MG; Jarman M
    Drug Metab Dispos; 1993; 21(6):1119-24. PubMed ID: 7905393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
    Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
    Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in breast tumour tissues.
    MacCallum J; Cummings J; Dixon JM; Miller WR
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):269-75. PubMed ID: 9367217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenografts.
    Robinson SP; Langan-Fahey SM; Jordan VC
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1769-76. PubMed ID: 2632258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone.
    Zhang F; Fan PW; Liu X; Shen L; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):53-62. PubMed ID: 10649967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.
    Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW
    J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational study of tamoxifen phase I metabolites using chromatographic and spectroscopic analytical techniques.
    Teunissen SF; Rosing H; Seoane MD; Brunsveld L; Schellens JH; Schinkel AH; Beijnen JH
    J Pharm Biomed Anal; 2011 Jun; 55(3):518-26. PubMed ID: 21392921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.